Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1103/PhysRevLett.54.174 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A comprehensive in silico genome-wide identification and characterization of SQUAMOSA promoter binding protein (SBP) gene family in Musa acuminata.
J Genet Eng Biotechnol
March 2025
Faculty of Biotechnology and Genetic Engineering, Sylhet Agricultural University, Sylhet 3100, Bangladesh; Department of Molecular Biology and Genetic Engineering, Sylhet Agricultural University, Sylhet 3100, Bangladesh. Electronic address:
One of the largest and most significant transcription factor gene families in plants is the SQUAMOSA promoter binding protein (SBP) gene family and they perform critical regulatory roles in floral enhancement, fruit development, and stress resistance. The SBP protein family (also known as SPL) has not yet been thoroughly studied in the staple fruit crop, banana. A perennial monocot plant, banana is essential for ensuring food and nutrition security.
View Article and Find Full Text PDFA Neuroimmune-Oncology Microphysiological Analysis Platform (NEO-MAP) for Evaluating Astrocytic Scar Formation and Microgliosis in Glioblastoma Microenvironment.
Adv Healthc Mater
March 2025
Institute of Quantum Biophysics, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
Glioblastoma multiforme (GBM) is the most aggressive type of brain tumor, characterized by its heterogeneity in cellular components, including reactive astrocytes and microglia. Since neuroimmune responses like astrogliosis and microgliosis gain recognition as vital factors in brain tumor progression, there is a growing need for clinically relevant models that assess the interactions between astrocytes, microglia, and GBM. Here, a NEuroimmune-Oncology Microphysiological Analysis Platform (NEO-MAP) is presented as a "new map" to observe astrocytic scar formation and microgliosis in response to GBM.
View Article and Find Full Text PDFAI-enhanced PET/CT image synthesis using CycleGAN for improved ovarian cancer imaging.
Pol J Radiol
January 2025
Nuclear Engineering Department, School of Mechanical Engineering, Shiraz University, Shiraz, Iran.
Purpose: Ovarian cancer is the fifth fatal cancer among women. Positron emission tomography (PET), which offers detailed metabolic data, can be effectively used for early cancer screening. However, proper attenuation correction is essential for interpreting the data obtained by this imaging modality.
View Article and Find Full Text PDFImpact of deep learning denoising on kinetic modelling for low-dose dynamic PET: application to single- and dual-tracer imaging protocols.
Eur J Nucl Med Mol Imaging
March 2025
Physics and Instrumentation, Department of Radiology, University of Pennsylvania, Philadelphia, PA, US.
Purpose: Long-axial field-of-view PET scanners capture multi-organ tracer distribution with high sensitivity, enabling lower dose dynamic protocols and dual-tracer imaging for comprehensive disease characterization. However, reducing dose may compromise data quality and time-activity curve (TAC) fitting, leading to higher bias in kinetic parameters. Parametric imaging poses further challenges due to noise amplification in voxel-based modelling.
View Article and Find Full Text PDFA comparative analysis of GEANT4, MCNP6 and FLUKA on proton-induced gamma-ray simulation.
Med Phys
March 2025
Division of Biomedical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Background: Precise range verification is essential in proton therapy to minimize treatment margins due to the steep dose fall-off of proton beams. The emission of secondary radiation from nuclear reactions between incident particles and tissues stands out as a promising method for range verification. Two prominent techniques are PET and Prompt Gamma-Ray Spectroscopy (PGS).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!